NIDA wishes to thank the following individuals for their guidance and comments during the development and review of this publication:
Karen L. Bierman, Ph.D.
Pennsylvania State University
Hyman Hops, Ph.D.
Oregon Research Institute
C. Hendricks Brown, Ph.D.
University of South Florida
Eugene R. Oetting, Ph.D.
Colorado State University
Richard R. Clayton, Ph.D.
University of Kentucky
Zili Sloboda, Sc.D.
University of Akron
Thomas J. Dishion, Ph.D.
University of Oregon
Richard Spoth, Ph.D.
Iowa State University
E. Michael Foster, Ph.D.
Pennsylvania State
John B. Reid, Ph.D.
University Oregon Social Learning Center
Meyer D. Glantz, Ph.D.
National Institute on Drug Abuse
Thomas A. Wills, Ph.D.
Albert Einstein College of Medicine
Mark T. Greenberg, Ph.D.
Pennsylvania State University
NIDA also would like to thank the Community Anti-Drug Coalitions of America (CADCA) for helping organize a focus group of community leaders in reviewing this publication.
This publication was written by Elizabeth B. Robertson, Ph.D., Susan L. David, M.P.H. (retired), and Suman A. Rao, Ph.D., National Institute on Drug Abuse.
The U.S. government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in the publication are used only because they are considered essential in the context of the studies described here.
This publication is available for your use and may be reproduced in its entirety without permission from NIDA. Citation of the source is appreciated, using the following language: Source: National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services.